Table 2 Number (percent) who reported requesting full blood count, renal and liver function tests by csDMARD, N = 210#
csDMARD | FBC (N, %)* | eGFR (N, %)* | LFT (N, %)* | None (N, %)* | Drug not prescribed (N, %)* |
|---|---|---|---|---|---|
Methotrexate | 209 (100%) | 199 (95%) | 210 (100%) | 2 (1%) | 0 (0%) |
Leflunomide | 205 (98%) | 186 (89%) | 204 (97%) | 1 (0%) | 5 (2%) |
Sulfasalazine | 204 (97%) | 175 (83%) | 201 (96%) | 3 (1%) | 3 (1%) |
Hydroxychloroquine | 76 (36%) | 68 (32%) | 60 (29%) | 128 (61%) | 0 (0%) |
Azathioprine | 208 (99%) | 187 (89%) | 206 (98%) | 1 (0%) | 2 (1%) |
Mycophenolate | 202 (96%) | 185 (88%) | 195 (93%) | 2 (1%) | 8 (4%) |
Tacrolimus and other Calcineurin Inhibitors | 135 (64%) | 134 (64%) | 129 (61%) | 3 (1%) | 74 (35%) |